CIR
CYTK icon

Clear Investment Research’s Cytokinetics CYTK Stock Holding History

Clear Investment Research’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-19
Closed – – 174
2019
Q3 		$0 Hold
19
– – ﹤0.01% 263
2019
Q2 		$0 Hold
19
– – ﹤0.01% 262
2019
Q1 		$0 Hold
19
– – ﹤0.01% 252
2018
Q4 		$0 Hold
19
– – ﹤0.01% 246
2018
Q3 		$0 Buy
+19
New +$152 ﹤0.01% 257

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Clear Investment Research's CYTK Position: Q4 2019 in Review

Clear Investment Research sold out of Cytokinetics (CYTK) in Q4 2019, closing a stake of 19 shares.

Clear Investment Research first reported a position in CYTK in Q3 2018 and held it in 5 quarters. The position peaked at $0 in Q3 2019. 142 funds tracked by Wall St. Rank hold CYTK as of Q4 2019.

  • Clear Investment Research reported no remaining Cytokinetics position as of Q4 2019 after selling out during the quarter.
  • Clear Investment Research sold 19 Cytokinetics shares in Q4 2019.
  • Clear Investment Research first reported a position in Cytokinetics in Q3 2018 and held it in 5 quarters.
  • Clear Investment Research's Cytokinetics position peaked at $0 in Q3 2019.
  • 142 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2019.

Based on Clear Investment Research's 13F filing for Q4 2019, filed 4 Feb 2020.